SEC Form 4 · accession 0000719135-18-000078
Apyx Medical Corp · APYX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew Makrides
Director
Period of report
Nov 8, 2018
Accepted (ET)
Nov 9, 2018 · 3:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000719135
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 8, 2018 | G | 2,000 | $6.84 | D | 609,972 | D | |
| Common StockF1 | Nov 8, 2018 | G | 2,000 | $6.84 | D | 607,972 | D | |
| Common StockF1 | Nov 8, 2018 | G | 2,000 | $6.84 | D | 605,972 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person owns an aggregate of 605,972 shares of the issuer's Common Stock following all of the transactions reported on this Form 4.